CIK 0002007919 · <br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $6,347,357
- in 7 filings
- Open-market sales, last 90 days
- $279,010
- in 2 filings
Net +$6,068,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +1,100 | $107.12 | $118K | 719,148 |
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +500 | $108.24 | $54K | 719,648 |
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +1,219 | $111.88 | $136K | 720,867 |
| 2026-09-08 | Lappe Mark Chief Executive Officer | Purchase | +9,681 | $112.28 | $1.1M | 730,548 |
| 2026-09-08 | FORSYTH DOUGLAS Director | Purchase | +2,500 | $114.65 | $287K | 227,064 |
| 2026-06-03 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-06-03 | Kayyem Jon Faiz Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-06-03 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-06-03 | MANHARD KIMBERLY Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-06-03 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-06-03 | Kayyem Jon Faiz Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-06-03 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-06-03 | MANHARD KIMBERLY Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-04-24 | Matly David President | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-10-07 | VIKING GLOBAL INVESTORS LP 10% owner | Sale | −308,643 | $32.25 | $10.0M | 1,267,823 |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP 10% owner | Sale | −16,315 | $32.25 | $526K | 67,018 |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP 10% owner | Sale | −25,042 | $32.25 | $808K | 102,864 |
| 2025-05-28 | MANHARD KIMBERLY Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-05-28 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-05-28 | Kayyem Jon Faiz Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 2 of 5 · 98 trades